Yet Another Way the Government Drives Up Pharmaceutical Prices
Social media exploded with outrage this week after American investor Martin Shkreli purchased the rights to sell the drug Daraprim and raised the price %5,000 percent from $13.50 to$750.
Shkreli was able to do this because federal law bans the importation of the drug. According to the International Business Times, a generic version of the drug is available in India at a price of 10 cents.